We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
SGCM
26
Sand Grove Capital Management
United Kingdom
– -$109M -2,369,707 Closed
Macquarie Group
27
Macquarie Group
Australia
– -$104M -2,242,208 Closed
Norges Bank
28
Norges Bank
Norway
– -$95.7M -2,066,511 Closed
AllianceBernstein
29
AllianceBernstein
Tennessee
– -$95.1M -2,052,554 Closed
ACA
30
Avoro Capital Advisors
New York
– -$92.7M -2,000,000 Closed
N
31
Nuveen
North Carolina
– -$92.3M -1,993,194 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$88M -1,899,080 Closed
DLPIC
33
Davide Leone & Partners Investment Company
United Kingdom
– -$84.2M -1,817,309 Closed
WIC
34
Water Island Capital
New York
– -$75.9M -1,638,000 Closed
OP
35
Omni Partners
United Kingdom
– -$73.4M -1,585,000 Closed
Wellington Management Group
36
Wellington Management Group
Massachusetts
– -$72.7M -1,569,465 Closed
Citigroup
37
Citigroup
New York
– -$71.3M -1,539,322 Closed
JP Morgan Chase
38
JP Morgan Chase
New York
– -$67.6M -1,462,833 Closed
Brown Advisory
39
Brown Advisory
Maryland
– -$65.1M -1,405,081 Closed
UBS AM
40
UBS AM
Illinois
– -$64.2M -1,386,525 Closed
Charles Schwab
41
Charles Schwab
California
– -$63.9M -1,379,207 Closed
Invesco
42
Invesco
Georgia
– -$63.2M -1,363,314 Closed
Renaissance Technologies
43
Renaissance Technologies
New York
– -$62.3M -1,344,652 Closed
Deutsche Bank
44
Deutsche Bank
Germany
– -$60.5M -1,305,214 Closed
UBS Group
45
UBS Group
Switzerland
– -$60.3M -1,301,849 Closed
MAM
46
Melqart Asset Management
United Kingdom
– -$59.4M -1,282,693 Closed
Two Sigma Advisers
47
Two Sigma Advisers
New York
– -$58.9M -1,272,213 Closed
FLAM
48
First Light Asset Management
Minnesota
– -$56.2M -1,212,545 Closed
BI
49
BVF Inc
California
– -$55.3M -1,193,224 Closed
PA
50
Perceptive Advisors
New York
– -$48.1M -1,038,390 Closed
1
2
3 4 5

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.